Back to ACAD
YOUSIF CAPITAL MANAGEMENT, LLC → ACAD
YOUSIF CAPITAL MANAGEMENT, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
4
Latest value
$694K
Q3 2026
Peak value
$903K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $903K |
| Q1 2026 | $758K |
| Q2 2026 | $867K |
| Q3 2026 | $694K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $694K | 34.4K | — | — |
| Q2 2026 | $867K | 34.3K | — | — |
| Q1 2026 | $758K | 34.0K | — | — |
| Q4 2025 | $903K | 34.4K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M